标题
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
作者
关键词
Multiple Sclerosis, Brain Volume, Grey Matter Volume, Fingolimod, Clinically Isolate Syndrome
出版物
CNS DRUGS
Volume 28, Issue 2, Pages 147-156
出版商
Springer Nature
发表日期
2014-01-21
DOI
10.1007/s40263-014-0140-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Evolution of Cortical and Thalamus Atrophy and Disability Progression in Early Relapsing-Remitting MS during 5 Years
- (2013) R. Zivadinov et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Sub-threshold cognitive impairment in multiple sclerosis: the association with cognitive reserve
- (2013) Anthony Feinstein et al. JOURNAL OF NEUROLOGY
- Brain atrophy and lesion load predict long term disability in multiple sclerosis
- (2013) Veronica Popescu et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage
- (2013) M. Filippi et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Active Cognitive Reserve Influences the Regional Atrophy to Cognition Link in Multiple Sclerosis
- (2013) Adam J. Booth et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Preventing brain atrophy should be the gold standard of effective therapy in MS (after the first year of treatment): Yes
- (2013) Richard A Rudick et al. Multiple Sclerosis Journal
- Preventing brain atrophy should be the gold standard of effective therapy in multiple sclerosis (after the first year of treatment): Commentary
- (2013) DL Arnold et al. Multiple Sclerosis Journal
- Preventing brain atrophy should be the gold standard of effective theraphy in MS (after the first year of treatment): No
- (2013) M Filippi et al. Multiple Sclerosis Journal
- Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes
- (2013) Angela Vidal-Jordana et al. Multiple Sclerosis Journal
- Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration
- (2013) H Kearney et al. Multiple Sclerosis Journal
- Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients
- (2013) Ralph HB Benedict et al. Multiple Sclerosis Journal
- Clinical impact of early brain atrophy in clinically isolated syndromes
- (2013) F Pérez-Miralles et al. Multiple Sclerosis Journal
- Cognitive reserve and cortical atrophy in multiple sclerosis: A longitudinal study
- (2013) M. P. Amato et al. NEUROLOGY
- Gray matter damage predicts the accumulation of disability 13 years later in MS
- (2013) M. Filippi et al. NEUROLOGY
- Cognitive impairment in MS: Impact of white matter integrity, gray matter volume, and lesions
- (2013) H. E. Hulst et al. NEUROLOGY
- Brain reserve and cognitive reserve in multiple sclerosis: What you've got and how you use it
- (2013) J. F. Sumowski et al. NEUROLOGY
- Localized grey matter atrophy in multiple sclerosis: A meta-analysis of voxel-based morphometry studies and associations with functional disability
- (2013) J. Lansley et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Relevance of Spinal Cord Abnormalities to Clinical Disability in Multiple Sclerosis: MR Imaging Findings in a Large Cohort of Patients
- (2013) Carsten Lukas et al. RADIOLOGY
- Thalamic Atrophy Is Associated with Development of Clinically Definite Multiple Sclerosis
- (2013) Robert Zivadinov et al. RADIOLOGY
- Reliability of Longitudinal Brain Volume Loss Measurements between 2 Sites in Patients with Multiple Sclerosis: Comparison of 7 Quantification Techniques
- (2012) F. Durand-Dubief et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis
- (2012) Ugo Nocentini et al. Brain Imaging and Behavior
- Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective, non-randomized pilot study
- (2012) E. Portaccio et al. EUROPEAN JOURNAL OF NEUROLOGY
- Voxel-wise mapping of cervical cord damage in multiple sclerosis patients with different clinical phenotypes
- (2012) Maria A Rocca et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Association between pathological and MRI findings in multiple sclerosis
- (2012) Massimo Filippi et al. LANCET NEUROLOGY
- Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome
- (2012) Giancarlo Comi et al. Multiple Sclerosis Journal
- Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
- (2012) Giancarlo Comi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Revisiting Brain Atrophy and Its Relationship to Disability in Multiple Sclerosis
- (2012) Navid Shiee et al. PLoS One
- Relevance of Brain Lesion Location to Cognition in Relapsing Multiple Sclerosis
- (2012) Francesca Rossi et al. PLoS One
- Regional Cervical Cord Atrophy and Disability in Multiple Sclerosis: A Voxel-based Analysis
- (2012) Paola Valsasina et al. RADIOLOGY
- The effect of daclizumab on brain atrophy in relapsing-remitting multiple sclerosis
- (2012) Isabela T. Borges et al. Multiple Sclerosis and Related Disorders
- A longitudinal study of brain volume changes in normal aging
- (2011) Hidemasa Takao et al. EUROPEAN JOURNAL OF RADIOLOGY
- Cortical pathology and cognitive impairment in multiple sclerosis
- (2011) Massimiliano Calabrese et al. Expert Review of Neurotherapeutics
- Human brain changes across the life span: A review of 56 longitudinal magnetic resonance imaging studies
- (2011) Anna M. Hedman et al. HUMAN BRAIN MAPPING
- Information processing speed, neural efficiency, and working memory performance in multiple sclerosis: Differential relationships with structural magnetic resonance imaging
- (2011) Thomas J. Covey et al. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
- Effect of disease-modifying therapies on brain volume in relapsing–remitting multiple sclerosis: Results of a five-year brain MRI study
- (2011) Omar Khan et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials
- (2011) Frederik Barkhof et al. Nature Reviews Neurology
- MRI predictors of cognitive outcome in early multiple sclerosis
- (2011) M. S. A. Deloire et al. NEUROLOGY
- Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline
- (2011) S. Debette et al. NEUROLOGY
- Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
- (2011) Paul O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Factors predisposing to the development of multiple sclerosis
- (2011) C. A. Young QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- MR Imaging of Multiple Sclerosis
- (2011) Massimo Filippi et al. RADIOLOGY
- Effect of immunomodulatory medication on regional gray matter loss in relapsing–remitting multiple sclerosis—A longitudinal MRI study
- (2010) Kerstin Bendfeldt et al. BRAIN RESEARCH
- Early central atrophy rate predicts 5 year clinical outcome in multiple sclerosis
- (2010) C. Lukas et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
- (2010) Raju Kapoor et al. LANCET NEUROLOGY
- Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes
- (2010) N. De Stefano et al. NEUROLOGY
- Ibudilast in relapsing-remitting multiple sclerosis: A neuroprotectant?
- (2010) F. Barkhof et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis
- (2010) Ranjan Dutta et al. PROGRESS IN NEUROBIOLOGY
- Thalamic Damage and Long-term Progression of Disability in Multiple Sclerosis
- (2010) Maria Assunta Rocca et al. RADIOLOGY
- Multiple sclerosis – candidate mechanisms underlying CNS atrophy
- (2010) Volker Siffrin et al. TRENDS IN NEUROSCIENCES
- Rate of Brain Atrophy in Benign vs Early Multiple Sclerosis
- (2009) Susan A. Gauthier et al. ARCHIVES OF NEUROLOGY
- Gray matter atrophy and disability progression in patients with early relapsing–remitting multiple sclerosis
- (2009) Dana Horakova et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A new window in multiple sclerosis pathology: non-conventional quantitative magnetic resonance imaging outcomes
- (2009) Frauke Zipp JOURNAL OF THE NEUROLOGICAL SCIENCES
- Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial
- (2009) Ludwig Kappos et al. LANCET NEUROLOGY
- 250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
- (2009) Paul O'Connor et al. LANCET NEUROLOGY
- Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis
- (2009) LK Fisniku et al. Multiple Sclerosis Journal
- Regulation of matrix metalloproteinases and their inhibitors by interferon-β: a longitudinal study in multiple sclerosis patients
- (2009) F Bernal et al. Multiple Sclerosis Journal
- Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
- (2009) Frederik Barkhof et al. Nature Reviews Neurology
- Association of matrix metalloproteinases with MRI indices of brain ischemia and aging
- (2009) José Rafael Romero et al. NEUROBIOLOGY OF AGING
- Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis
- (2009) R. Zivadinov et al. NEUROLOGY
- Gray matter atrophy in multiple sclerosis: A longitudinal study
- (2008) Elizabeth Fisher et al. ANNALS OF NEUROLOGY
- Gray matter atrophy is related to long-term disability in multiple sclerosis
- (2008) Leonora K. Fisniku et al. ANNALS OF NEUROLOGY
- Regional hippocampal atrophy in multiple sclerosis
- (2008) N. L. Sicotte et al. BRAIN
- Long-term global and regional brain volume changes following severe traumatic brain injury: A longitudinal study with clinical correlates
- (2008) A SIDAROS et al. NEUROIMAGE
- Brain Atrophy Assessment in Multiple Sclerosis: Importance and Limitations
- (2008) Antonio Giorgio et al. NEUROIMAGING CLINICS OF NORTH AMERICA
- Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
- (2008) R. Zivadinov et al. NEUROLOGY
- Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- The Immunology of Multiple Sclerosis
- (2008) Amit Bar-Or SEMINARS IN NEUROLOGY
- Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters
- (2007) A Minneboo et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search